Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
No family or circle of friends lies outside the reach of skin cancer — 1 in 5 ... The three main categories of skin cancer differ in terms of prognosis and their ... that increase theimmune system defense against abnormal cells, and they ..
Personalized cancer therapy is no longer just an exciting prospect, and ... The newest innovations, which activate the immune system, work even ..
There are studies that shows that prostate cancer and breast cancer can be treated by regular consumption of tomatoes. Tomatoes have a high level ..
| WFDD |
The holy grail of health care, arguably, is a cure for cancer. ... So a neat trick would be getting the body's immune system to one-up these tumors and ..
Monday Medical: New technology for stopping skin cancer ... system so the immune system can become more active and help to fight the cancer.”
| WA today |
The aim of oncolytic immunotherapy is to stimulate a patient's immune system to fight the growth of cancer cells. Patients are typically injected with .
The company says the dye also damages blood vessels in the tumor and may stimulate the immune system into attacking other tumor cells. The Phase ..
... and are one of the most important first responders against viral-infected and cancercells. With clear functions in the innate immune system, however ..
There seems to be some new discovery concerning cancer on a daily ... it targets the interaction between theimmune system and cancerous cells, ..
After researching statistics regarding cancer in the UAE, we found that the most ... Leukemia was the most common cancer found among children. ... only affect children under the age of four because the immune system is not fully ..
Patient Access to New Cancer Treatments
This slide show looks at patient access to oncology agents both in the United States and abroad, and examines barriers and other constraints preventing new treatments from getting into the hands of patients
This slide show looks at patient access to oncology agents both in the United States and abroad, and examines barriers and other constraints preventing new treatments from getting into the hands of patients
PRA was awarded a global, full-service Phase II pancreatic cancer trial by a biotech client. The project was originally launched by a different company .
Celgene is working with the China Food and Drug Administration to get permission to market Abraxane to treat pancreatic cancer, which has been ..
Doctors caught Daryl's cancer early, which is unusual for pancreatic cancer. Patients often have no early symptoms. Because Fair caught it early ..
Science Daily Cancer News
Patience and persistence are beginning to pay off for one researcher whose research about the behavior of cell proteins in childhood cancer was started by identifying a large number of signaling proteins using mass spectrometry. He collected more data than he knew what to do with, he says.
Scientists have gained ground toward developing more targeted therapies for the most common childhood brain tumor. The findings involve the DDX3X gene. In 2012, other work highlighted DDX3X as a promising focus for efforts to develop targeted therapies against medulloblastoma. Such treatments target the genetic mistakes that give rise to the brain tumor’s four subtypes
Therapies that specifically target mutations in a person's cancer have been much-heralded in recent years, yet cancer cells often find a way around them. To address this, researchers identified a promising combinatorial approach to treating glioblastomas, the most common form of primary brain cancer.
Childhood exposure to ionizing radiation increases lifetime malignancy risk, but a team of researchers has found that with just a little bit of education, the risk can be significantly reduced. Currently, up to 40% of computed tomography, or CT, scans are ordered (for everyone) unnecessarily
Mexico is the second largest economy in Latin America -- and its population is aging rapidly. Researchers offer new predictions and suggestions for lessening the impact of Mexico's cancer burden
Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. Researchers are working to determine what genetic factors and other characteristics might make prostate cancer patients more likely to experience hot flashes during and after therapy.
A method to help shorten the road to better cancer treatment has been developed by an international team of researchers. When DNA is damaged, several different proteins start pouring in to repair the damage; their types depend on the damage done. Up until now, it has been common practice to study one protein at a time, but by way of so-called mass spectrometry, researchers are now able to simultaneously see all the proteins that help repair damaged DNA
Tambahkan Komentar